Nouveaux anticoagulants oraux dans le traitement curatif de la maladie thromboembolique veineuse

详细信息    查看全文

• 作者：Laurent Bertoletti ; Jean-Christophe Lega ; Nathalie Moulin ; Andr¨¦a Buchmuller ; Patrick Mismetti ; Herv¨¦ Decousus
• 刊名：La Presse M|dicale
• 出版年：2013
• 出版时间：September, 2013
• 年：2013
• 卷：42
• 期：9_part_P1
• 页码：1232-1238
• 全文大小：238 K

文摘

| Figures/TablesFigures/Tables | ReferencesReferences

Key points

Rivaroxaban (with initial increased dosage) may be used as a stand-alone therapy in patients with venous thrombo-embolism.

The development of new anticoagulant drugs opened several options in the management of venous thrombo-embolism.

The efficacy and safety of these new oral anticoagulants in specific population as elderly and those with renal impairment deserve future research.

At that time, only rivaroxaban is licensed in France, in the treatment of deep venous thrombosis.